8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Jan 24, 2012)

Filed January 24, 2012For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on January 24, 2012, primarily to announce its fourth-quarter and full-year 2011 financial results. The report includes a press release detailing sales and earnings for the quarter ended January 1, 2012. This filing provides investors with the company's latest financial performance data, crucial for assessing the health and trajectory of JNJ's business segments, including Pharmaceuticals, Medical Devices, and Consumer Health.

Key Highlights

  • 1Announcement of Q4 2011 and full-year 2011 sales and earnings results.
  • 2Filing includes an official press release detailing financial performance for the quarter ended January 1, 2012.
  • 3Supplementary sales data and condensed consolidated statements of earnings for Q4 2011 are provided.
  • 4Key financial metrics released allow investors to gauge JNJ's revenue generation and profitability.
  • 5Information released is critical for understanding trends across JNJ's diverse business segments.
  • 6This 8-K serves as the primary official channel for disseminating these important financial updates to the market.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce Johnson & Johnson's financial results for the fourth quarter ended January 1, 2012, and the full year 2011, along with providing supplementary financial information.

The detailed financial results are provided in Exhibit 99.15 (the press release dated January 24, 2012) and Exhibit 99.2O (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fourth quarter).

Investors should focus on key metrics such as total sales, net earnings, earnings per share (EPS), and sales performance by segment (Pharmaceuticals, Medical Devices, and Consumer Health) to understand the company's operational performance and financial condition.

While this 8-K primarily reports on past results, the accompanying press release (Exhibit 99.15) would typically contain management commentary and potentially any updated financial guidance or outlook provided by the company for the upcoming period.